The microbiome has an impact on every organ in the body. It is associated with every chronic disease that affects humans. For the past few years, research has focused on cataloguing what microbes are present on and in our bodies, and connecting those microbes to specific diseases. The next step is to find out how those microbes function and interact during times of health and disease. With that knowledge, scientists hope to harness the power of the microbiome to develop preventive and therapeutic approaches to promote human health.
The University of Calgary will be at the forefront of that research. With support from the Canadian Institutes of Health Research (CIHR), Dr. Kathy McCoy, PhD, the scientific director of the International Microbiome Centre (IMC) at UCalgary, has brought together a “brain trust” of microbiome experts from across the country to develop research protocols and provide advice.
The Integrated Microbiome Platforms for Advancing Causation Testing and Translation, or IMPACTT, includes a cross-disciplinary group of investigators made up of microbiologists, immunologists, epidemiologists, clinician scientists, ethicists, sex/gender champions, and computational biologists from British Columbia, Alberta, Saskatchewan, Ontario, Quebec, and Nova Scotia.
Read more at: UToday